Skip to main content
. 2023 Mar 13;27:110. doi: 10.1186/s13054-023-04397-7

Table 1.

Baseline characteristics according to allocated group

Characteristics MB (n = 45) Control (n = 46)
Age—years, median (IQR) 46 (38–54) 47 (31–60)
Female sex—no. (%) 18 (40) 18 (40)
Hypertension—no. (%) 17 (38) 18 (39)
Diabetes—no. (%) 19 (42) 17 (37)
Acute kidney injury—no. (%) 22 (49) 20 (44)
Infection source—no. (%)
 Pneumonia—no. (%) 22 (49) 23 (50)
 Intra-abdominal—no. (%) 17 (38) 18 (39)
 Urinary tract—no. (%) 4 (9) 4 (9)
 Other—no. (%) 2 (4) 1 (2)
Shock diagnosis to intervention—hours, mean (SD) 8.3 ± 1.7 7.6 ± 2.3
Positive fluid response at enrollment— no. (%) 22 (49) 20 (44)
Fluid load from shock diagnosis to intervention—ml/kg, mean (SD) 24 ± 8.4 22 ± 9.6
Heart rate, mean (SD) 114 ± 9.9 115 ± 10.5
Mean arterial pressure—mmHg, mean (SD) 68 ± 4.5 67 ± 4.3
Norepinephrine dose—mcg/kg/min), median (IQR) 0.45 (0.27–0.68) 0.37 (0.20–0.58)
Vasopressin use—no. (%) 36 (80) 34 (74)
Serum lactate—mmol/L, median (IQR) 6.3 (4.8–7.4) 5.0 (2.9–7.5)
Mechanical ventilation—no. (%) 42 (93) 38 (82)
ARDS—no. (%) 36 (80) 32 (70)
PaO2/FIO2 ratio (SD) 190 ± 73 219 ± 79
PEEP—cmH2O, IQR 8 (6–8.5) 7 (6–9)
Serum creatinine—mg/dL, median (IQR) 1.5 (0.7–2.5) 1.5 (0.8–2.1)
Serum bilirubin—mg/dL, median (IQR) 1.4 (1.1–1.7) 1.3 (0.8–1.6)
AST—mg/dL, median (IQR) 113 (99–142) 107 (75–163)
ALT—mg/dL, median (IQR) 48 (41–78) 39 (30–79)
Ejection fraction—%, median (IQR) 61 (55–70) 58 (54–66)
SOFA, median (IQR) 10 (8–12) 10 (8–12)
APACHE II, mean (SD) 22.9 ± 4.4 22.4 ± 4.4

Plus–minus values are means ± standard deviation (SD); median with interquartile ranges (IQR) are in parentheses

MB methylene blue, ARDS acute respiratory distress syndrome, PEEP positive end-expiratory pressure, AST aspartate aminotransferase, ALT alanine aminotransferase, APACHE Acute Physiology and Chronic Health Evaluation